Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

NCT07307872 is registered in ClinicalTrials.gov with Amoneta Diagnostics SAS as lead sponsor.

NCT NCT07307872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07307872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease
Lead sponsor
Amoneta Diagnostics SAS
Phase
Observational
Overall status
Completed
Start date
March 23, 2017
Completion date
December 1, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad), dementia, frontotemporal dementia (ftd), neurodegenerative disease